| Bioactivity | HL22 is a harmaline derivative. HL22 significantly inhibits HCT116, MGC803 and MCF7 cancer cell lines, and inhibits MGC803 cell migration and monoclonal formation. The anti-cancer mechanism of HL22 is related to a variety of metabolic pathways and can be used in the study of cancer[1]. |
| Formula | C31H34N4O2 |
| Molar Mass | 494.63 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Liu Y, et al. Synthesis of harmaline N-9 derivatives and investigation of in vitro anticancer activity. Bioorg Med Chem Lett. 2025 Jan 13;119:130106. |